Cargando…
Randomized controlled trial: Standard versus supplemental bowel preparation in patients with Bristol stool form 1 and 2
BACKGROUND: Bristol stool form 1 and 2 is an important predictor of inadequate bowel preparation. AIM: To evaluate the efficacy of supplemental preparation in bowel cleansing quality among patients with Bristol stool form 1 and 2, as well as the feasibility of tailored bowel preparation guided by Br...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328251/ https://www.ncbi.nlm.nih.gov/pubmed/28241037 http://dx.doi.org/10.1371/journal.pone.0171563 |
_version_ | 1782510869981167616 |
---|---|
author | Li, Yueyue Jia, Xinyong Liu, Baozhen Qi, Yanmei Zhang, Xiubin Ji, Rui Yu, Yanbo Zuo, Xiuli Li, Yanqing |
author_facet | Li, Yueyue Jia, Xinyong Liu, Baozhen Qi, Yanmei Zhang, Xiubin Ji, Rui Yu, Yanbo Zuo, Xiuli Li, Yanqing |
author_sort | Li, Yueyue |
collection | PubMed |
description | BACKGROUND: Bristol stool form 1 and 2 is an important predictor of inadequate bowel preparation. AIM: To evaluate the efficacy of supplemental preparation in bowel cleansing quality among patients with Bristol stool form 1 and 2, as well as the feasibility of tailored bowel preparation guided by Bristol stool form scale. METHODS: Patients with Bristol stool form 1 and 2 from 3 Chinese tertiary hospitals randomly received either 2 L PEG-ELP (group A) or 10 mg bisacodyl plus 2 L PEG-ELP (group B); patients with Bristol stool form 3 to 7 received 2 L PEG-ELP (group C) for bowel preparation. The primary endpoint is the rate of adequate bowel reparation for the whole colon. The adequate bowel preparation rate for separate colon segments, the polyp detection rate (PDR), tolerability, acceptability, sleeping quality and compliance were evaluated as secondary endpoints. RESULTS: 700 patients were randomized. In per-protocol analysis, patients in group B attained significantly higher successful preparation rate than group A (88.7% vs. 61.2%, p<0.001) and similar with group C (88.7% vs. 85.0%, p = 0.316). The PDR in group B was significantly higher than group A (43.2% vs. 25.7%, p<0.001). Acceptability was much higher in group B and C. CONCLUSIONS: 10 mg bisacodyl plus 2 L PEG-ELP can significantly improve both bowel preparation quality and PDR in patients with Bristol stool form 1 and 2. Bristol stool form scale may be an easy and efficient guide for tailored bowel preparation before colonoscopy. |
format | Online Article Text |
id | pubmed-5328251 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-53282512017-03-09 Randomized controlled trial: Standard versus supplemental bowel preparation in patients with Bristol stool form 1 and 2 Li, Yueyue Jia, Xinyong Liu, Baozhen Qi, Yanmei Zhang, Xiubin Ji, Rui Yu, Yanbo Zuo, Xiuli Li, Yanqing PLoS One Research Article BACKGROUND: Bristol stool form 1 and 2 is an important predictor of inadequate bowel preparation. AIM: To evaluate the efficacy of supplemental preparation in bowel cleansing quality among patients with Bristol stool form 1 and 2, as well as the feasibility of tailored bowel preparation guided by Bristol stool form scale. METHODS: Patients with Bristol stool form 1 and 2 from 3 Chinese tertiary hospitals randomly received either 2 L PEG-ELP (group A) or 10 mg bisacodyl plus 2 L PEG-ELP (group B); patients with Bristol stool form 3 to 7 received 2 L PEG-ELP (group C) for bowel preparation. The primary endpoint is the rate of adequate bowel reparation for the whole colon. The adequate bowel preparation rate for separate colon segments, the polyp detection rate (PDR), tolerability, acceptability, sleeping quality and compliance were evaluated as secondary endpoints. RESULTS: 700 patients were randomized. In per-protocol analysis, patients in group B attained significantly higher successful preparation rate than group A (88.7% vs. 61.2%, p<0.001) and similar with group C (88.7% vs. 85.0%, p = 0.316). The PDR in group B was significantly higher than group A (43.2% vs. 25.7%, p<0.001). Acceptability was much higher in group B and C. CONCLUSIONS: 10 mg bisacodyl plus 2 L PEG-ELP can significantly improve both bowel preparation quality and PDR in patients with Bristol stool form 1 and 2. Bristol stool form scale may be an easy and efficient guide for tailored bowel preparation before colonoscopy. Public Library of Science 2017-02-27 /pmc/articles/PMC5328251/ /pubmed/28241037 http://dx.doi.org/10.1371/journal.pone.0171563 Text en © 2017 Li et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Li, Yueyue Jia, Xinyong Liu, Baozhen Qi, Yanmei Zhang, Xiubin Ji, Rui Yu, Yanbo Zuo, Xiuli Li, Yanqing Randomized controlled trial: Standard versus supplemental bowel preparation in patients with Bristol stool form 1 and 2 |
title | Randomized controlled trial: Standard versus supplemental bowel preparation in patients with Bristol stool form 1 and 2 |
title_full | Randomized controlled trial: Standard versus supplemental bowel preparation in patients with Bristol stool form 1 and 2 |
title_fullStr | Randomized controlled trial: Standard versus supplemental bowel preparation in patients with Bristol stool form 1 and 2 |
title_full_unstemmed | Randomized controlled trial: Standard versus supplemental bowel preparation in patients with Bristol stool form 1 and 2 |
title_short | Randomized controlled trial: Standard versus supplemental bowel preparation in patients with Bristol stool form 1 and 2 |
title_sort | randomized controlled trial: standard versus supplemental bowel preparation in patients with bristol stool form 1 and 2 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328251/ https://www.ncbi.nlm.nih.gov/pubmed/28241037 http://dx.doi.org/10.1371/journal.pone.0171563 |
work_keys_str_mv | AT liyueyue randomizedcontrolledtrialstandardversussupplementalbowelpreparationinpatientswithbristolstoolform1and2 AT jiaxinyong randomizedcontrolledtrialstandardversussupplementalbowelpreparationinpatientswithbristolstoolform1and2 AT liubaozhen randomizedcontrolledtrialstandardversussupplementalbowelpreparationinpatientswithbristolstoolform1and2 AT qiyanmei randomizedcontrolledtrialstandardversussupplementalbowelpreparationinpatientswithbristolstoolform1and2 AT zhangxiubin randomizedcontrolledtrialstandardversussupplementalbowelpreparationinpatientswithbristolstoolform1and2 AT jirui randomizedcontrolledtrialstandardversussupplementalbowelpreparationinpatientswithbristolstoolform1and2 AT yuyanbo randomizedcontrolledtrialstandardversussupplementalbowelpreparationinpatientswithbristolstoolform1and2 AT zuoxiuli randomizedcontrolledtrialstandardversussupplementalbowelpreparationinpatientswithbristolstoolform1and2 AT liyanqing randomizedcontrolledtrialstandardversussupplementalbowelpreparationinpatientswithbristolstoolform1and2 |